NCT ID | NCT02888743 |
Title | Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer |
Recruitment | Recruiting |
Gender | both |
Phase | Phase II |
Variant Requirements | yes |
Sponsors | National Cancer Institute (NCI) |
Indications | |
Therapies | |
Age Groups: | senior adult |